COPD patients have defective innate immunity, characterised in part by macrophage dysfunction. In established disease, both monocyte derived macrophages (MDM) and alveolar macrophages (AM), have impaired phagocytosis of bacteria and apoptotic cells (efferocytosis). Failure to adequately efferocytose dying cells leads to further release of inflammatory mediators and ongoing recruitment of immune cells, culminating in inflammation that is both damaging and ineffective. The transcription factor, Nrf2 is the master regulator of the antioxidant-response-element. Previous work using the non specific Nrf2 agonist, Sulforaphane, has partially restored defective bacterial phagocytosis in COPD AMs, however the specificity and mechanism of action in this context remains unknown. The role of Nrf2 activation in restoring macrophage efferocytosis in COPD has yet to be examined. We questioned if impaired macrophage phagocytosis and efferocytosis in COPD share a common mechanism and consequently if the defect in macrophage efferocytosis can be therapeutically manipulated using highly selective Nrf2 agonists. AMs and MDMs were isolated from patients with established COPD (GOLD stage 1-3). Macrophage efferocytosis of apoptotic neutrophils from each donor was correlated with bacterial internalisation of Streptococcus pneumoniae. Efferocytosis assays were carried out in the presence or absence of Sulforaphane and Compound 7, a highly specific Nrf2 agonist (supplied by GSK). Both COPD MDMs and AMs have significantly impaired phagocytosis of bacteria and apoptotic cells compared to Healthy Controls (p values all<0.05). Moreover, there was a correlation between donor macrophage phagocytosis of apoptotic cells and of bacteria (r=0.71). In vitro studies using Sulforaphane enhanced efferocytosis of apoptotic cells in both COPD MDMs and AMs (p<0.01). This effect was replicated using Compound 7 in both MDMs (p=<0.05) and AMs. This was more pronounced in current smokers. In summary, we observe a correlation between impaired macrophage phagocytosis and efferocytosis in COPD, suggesting a common mechanism. Furthermore, we describe partial rescue of defective COPD MDM and AM efferocytosis by Sulforaphane and via specific activation of the Nrf2 pathway using Compound 7. Together, these data highlight the importance of the Nrf2 pathway in reversing macrophage dysfunction in COPD patients and provide key mechanistic insights into the underlying defect.
S116

CELL-DISSOCIATED HAEMOPHILUS INFLUENZAE AND BACTERIA-ASSOCIATED INFLAMMATORY MEDIATORS IN THE AIRWAYS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
these levels differ over an exacerbation time course. We sought to investigate the effects of Haemophilius influenzae cell-interaction upon airway inflammation and whether the levels of H. influenzae bacteria and cell-dissociated bacteria differ over an exacerbation time course. Methods Cell differential counts were carried out on sputum samples as per standard protocol. Bacterial DNA was extracted and H.influenzae was quantified using qPCR from the sputum plug (contains cell-associated and dissociated bacteria) and the sputum cell-free supernatant (cell-dissociated bacteria only). Inflammatory mediators (IL-1a, TNF-a, IL-8 and neutrophil elastase (NE)) were measured in the sputum supernatant using commercial assays. Results 63 patients (77% male; average age of 69 (45-88); FEV 1 percentage predicted of 53%; mean percentage neutrophil count in sputum of 65%) at stable state were analysed. Levels of H. influenzae in the supernatant only correlated with the sputum total cell count (r=0.38; p=0.03). Levels of H. influenzae in the plug correlated with inflammatory mediators (sputum neutrophil percentage r=0.42, p=0.01; sputum macrophage percentage r=À0.35, p=0.04; IL-1a r=0.36, p=0.03; IL-8 r=0.49, p<0.01; NE r=0.40, p=0.02). The exacerbation time course in 10 paired COPD subjects was examined. There was no significant difference in H. influenzae levels in the plug (p=0.89) ( figure 1A ). However, there was a significant increase in levels in the supernatant over the exacerbation time course (p=0.05) ( figure 1B) . Conclusion H. influenzae levels in the sputum plug appear to have much more of an effect on airway inflammation than levels of cell-dissociated H. influenzae suggesting that cell-associated bacteria may be a driver of airway inflammation in COPD. Further investigation into this highly complicated relationship needs to be conducted.
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THE EFFECT OF CIGARETTE AND ELECTRONIC CIGARETTE VAPOUR ON BACTERIA IN CHRONIC LUNG INFECTION
Introduction Cigarette smoke is a risk factor for the development of several chronic lung diseases, e.g., Chronic Obstructive Respiratory Disease (COPD) and bronchiectasis. This study aims to determine the effect of cigarette smoke and electronic cigarette vapour, on key bacteria involved in the progression and exacerbation of chronic lung disease. Methods Cigarette smoke extract (CSE) and electronic cigarette vapour extract (ECVE) were prepared using a modified syringe driver apparatus and bubbling through appropriate growth media. Reference isolates [Haemophilus influenzae, ATCC49766 (HI), Streptococcus pneumoniae ATCC49619 (SP), Staphylococcus aureus ATCC29213 (SA) and Pseudomonas aeruginosa ATCC 27853 (PA)] were grown in broth +/-CSE or ECVE. Biofilm formation and survival in the Galleria mellonella infection model, following bacterial exposure to CSE/ECVE were determined. Levels of IL-8 and TNFa secretion from A549 cells, following infection by bacteria+/-CSE/ ECVE and addition of cell-signalling inhibitors, were measured by ELISA.
Results A trend towards increased biofilm formation following exposure to either CSE or ECVE was observed, which reached statistical significance with SP and PA +CSE (p=0.0047 and 0.0043, respectively) and SA+ECVE (p<0.001). There was decreased survival of Galleria mellonella following infection with bacteria+CSE/ECVE vs. bacteria only, suggestive of increased virulence; this was statistically significant in the case of HI (p=0.016) and PA (p=0.0005) +CSE. Statistically significant increases in IL-8 secretion in A549 cells were observed for HI and PA +CSE and SA +ECVE, and in TNFa, with SP and SA+ECVE. However, a clear trend towards increases in both cytokines following CSE/ ECVE exposure was evident, with little difference observed between CSE/ECVE. Addition of pathway inhibitors following A549 cell infection with bacteria+CSE/ECVE resulted in a decrease in IL-8 or TNFa via the same pathways as with bacteria alone. Conclusion Exposure of bacteria involved in the pathogenesis of chronic lung infection to both CSE and EVCE resulted in increased virulence, biofilm formation, and inflammation, and may contribute to establishment of chronic infection and persistence. Further work is required to determine the clinical effects of ECVE. Rationale Idiopathic pulmonary fibrosis is a chronic fibroproliferative disease with a median survival of approximately 3 years. avb6 integrins are upregulated in lung fibrosis and are associated with increased activation of the profibrotic cytokine TGF-b. The transcription factor Elk1 can repress gene expression of b6. We therefore hypothesise that animals lacking functional Elk1 (Elk1 -/0 ) will develop age related pulmonary fibrosis. Methods Elk1 knock-out (Elk1 -/0 ) and wild-type (Elk1
Of mice and men
) mice were allowed to age for 365 days. At 365 days old mice were sacrificed and their lungs harvested for evaluation of collagen gene expression, lung hydroxyproline concentration and histological assessment. Results Lungs were extracted and lung wet weights were measured in Elk1 -/0 mice and wild-type (Elk1 +/0 ) controls and no significant difference between the two genotypes was shown (175.7 mg, 161.8 mg respectively n=6-8). However, assessment of total lung hydroxyproline established that there was significantly more hydroxyproline in Elk1 -/0 mice compared with Elk1 +/0 controls (852.3, 758.4 mg/lung set, respectively, n=5-8, p=0.0346). Assessment of Masson's trichrome stained Elk1 -/0 lung tissue sections found a small number of fibrotic lesions were present. Furthermore, there was a trend towards increased alveolar wall median thickness in Elk1 -/0 mice compared with Elk1 +/0 animals (5.94 vs 5.56 mm respectively). In a small number of 12 week old mice we identified a trend towards increased a-smooth muscle actin (aSMA) mRNA expression in the lungs of Elk1 -/0 mice compared with
